A detailed history of Natixis Advisors, L.P. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 502,083 shares of TMO stock, worth $266 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
502,083
Previous 417,373 20.3%
Holding current value
$266 Million
Previous $231 Million 34.56%
% of portfolio
0.61%
Previous 0.5%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$531.86 - $624.21 $45.1 Million - $52.9 Million
84,710 Added 20.3%
502,083 $311 Million
Q2 2024

Aug 01, 2024

BUY
$541.52 - $599.02 $22.2 Million - $24.5 Million
40,942 Added 10.88%
417,373 $231 Million
Q1 2024

Apr 25, 2024

BUY
$528.82 - $599.43 $22.9 Million - $26 Million
43,333 Added 13.01%
376,431 $219 Million
Q4 2023

Feb 06, 2024

BUY
$431.41 - $532.94 $1.82 Million - $2.25 Million
4,214 Added 1.28%
333,098 $177 Million
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $29.8 Million - $34.3 Million
59,716 Added 22.19%
328,884 $166 Million
Q2 2023

Aug 15, 2023

SELL
$508.46 - $591.13 $4.72 Million - $5.48 Million
-9,276 Reduced 3.33%
269,168 $140 Million
Q1 2023

May 11, 2023

BUY
$535.0 - $604.82 $14.6 Million - $16.5 Million
27,213 Added 10.83%
278,444 $160 Million
Q4 2022

Jan 27, 2023

BUY
$484.71 - $571.37 $14.9 Million - $17.5 Million
30,706 Added 13.92%
251,231 $138 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $13 Million - $15.5 Million
25,639 Added 13.16%
220,525 $112 Million
Q2 2022

Aug 12, 2022

BUY
$500.9 - $612.21 $3.58 Million - $4.37 Million
7,144 Added 3.81%
194,886 $106 Million
Q1 2022

May 12, 2022

SELL
$524.0 - $644.92 $34.7 Million - $42.7 Million
-66,239 Reduced 26.08%
187,742 $111 Million
Q4 2021

Feb 08, 2022

BUY
$569.0 - $667.24 $1.95 Million - $2.29 Million
3,431 Added 1.37%
253,981 $169 Million
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $3.09 Million - $3.69 Million
6,056 Added 2.48%
250,550 $143 Million
Q2 2021

Aug 12, 2021

BUY
$441.0 - $508.24 $16.1 Million - $18.5 Million
36,479 Added 17.54%
244,494 $123 Million
Q1 2021

May 05, 2021

SELL
$439.85 - $518.83 $13.5 Million - $15.9 Million
-30,607 Reduced 12.83%
208,015 $94.9 Million
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $4 Million - $4.85 Million
9,200 Added 4.01%
238,622 $111 Million
Q3 2020

Nov 12, 2020

SELL
$359.77 - $441.52 $11.4 Million - $14 Million
-31,691 Reduced 12.14%
229,422 $101 Million
Q2 2020

Aug 11, 2020

BUY
$275.2 - $362.34 $8.11 Million - $10.7 Million
29,478 Added 12.73%
261,113 $94.6 Million
Q1 2020

Apr 27, 2020

BUY
$255.3 - $340.05 $4.58 Million - $6.1 Million
17,927 Added 8.39%
231,635 $65.7 Million
Q4 2019

Feb 10, 2020

SELL
$271.93 - $328.04 $1.76 Million - $2.12 Million
-6,467 Reduced 2.94%
213,708 $69.4 Million
Q3 2019

Nov 12, 2019

BUY
$268.46 - $305.43 $1.64 Million - $1.86 Million
6,101 Added 2.85%
220,175 $64.1 Million
Q2 2019

Aug 12, 2019

BUY
$257.51 - $295.55 $2.17 Million - $2.49 Million
8,427 Added 4.1%
214,074 $62.9 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $1.51 Million - $1.94 Million
7,094 Added 3.57%
205,647 $56.3 Million
Q4 2018

Feb 13, 2019

BUY
$208.47 - $251.98 $218,476 - $264,075
1,048 Added 0.53%
198,553 $44.4 Million
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $2.15 Million - $2.55 Million
10,443 Added 5.58%
197,505 $48.2 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $3.55 Million - $3.84 Million
17,475 Added 10.3%
187,062 $0
Q1 2018

May 10, 2018

BUY
$192.98 - $224.11 $2.02 Million - $2.34 Million
10,460 Added 6.57%
169,587 $35 Million
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $1.05 Million - $1.15 Million
5,752 Added 3.75%
159,127 $30.2 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $26.3 Million - $29.8 Million
153,375
153,375 $29 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $208B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.